Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Otitis Media | 3 | 2020 | 106 | 1.46 | Why? |
| Adenoidectomy | 1 | 2017 | 41 | 0.70 | Why? |
| Conjunctivitis, Allergic | 1 | 2019 | 94 | 0.69 | Why? |
| Tonsillitis | 1 | 2017 | 67 | 0.65 | Why? |
| Bronchiolitis | 1 | 2021 | 297 | 0.64 | Why? |
| Tonsillectomy | 1 | 2017 | 115 | 0.63 | Why? |
| Pediatrics | 3 | 2020 | 2969 | 0.40 | Why? |
| Intellectual Disability | 3 | 2018 | 391 | 0.35 | Why? |
| Vitamin D Deficiency | 1 | 2019 | 1782 | 0.29 | Why? |
| Vitamin D | 1 | 2019 | 2904 | 0.25 | Why? |
| Otorhinolaryngologic Diseases | 2 | 2020 | 491 | 0.24 | Why? |
| Otitis Media with Effusion | 1 | 2021 | 39 | 0.22 | Why? |
| Italy | 11 | 2021 | 38444 | 0.21 | Why? |
| Meningitis, Listeria | 1 | 2018 | 4 | 0.20 | Why? |
| Polydactyly | 1 | 2018 | 2 | 0.20 | Why? |
| Megalencephaly | 1 | 2018 | 3 | 0.20 | Why? |
| 46, XX Disorders of Sex Development | 1 | 2018 | 4 | 0.19 | Why? |
| Mullerian Ducts | 1 | 2018 | 6 | 0.19 | Why? |
| Ampicillin | 1 | 2018 | 73 | 0.19 | Why? |
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2018 | 11 | 0.19 | Why? |
| Rubinstein-Taybi Syndrome | 1 | 2018 | 6 | 0.19 | Why? |
| Aniridia | 1 | 2018 | 5 | 0.19 | Why? |
| Craniofacial Abnormalities | 1 | 2018 | 33 | 0.19 | Why? |
| Chromosome Disorders | 1 | 2018 | 24 | 0.19 | Why? |
| RNA Splice Sites | 1 | 2018 | 40 | 0.19 | Why? |
| Histiocytic Necrotizing Lymphadenitis | 1 | 2018 | 23 | 0.19 | Why? |
| Gentamicins | 1 | 2018 | 76 | 0.19 | Why? |
| Child | 19 | 2021 | 70012 | 0.19 | Why? |
| Listeria monocytogenes | 1 | 2018 | 68 | 0.18 | Why? |
| Tympanic Membrane | 1 | 2017 | 6 | 0.18 | Why? |
| Ophthalmic Solutions | 1 | 2019 | 136 | 0.18 | Why? |
| Frameshift Mutation | 1 | 2018 | 158 | 0.17 | Why? |
| Lymphadenitis | 1 | 2018 | 53 | 0.17 | Why? |
| Cerebellar Ataxia | 1 | 2018 | 78 | 0.17 | Why? |
| Causality | 1 | 2021 | 857 | 0.16 | Why? |
| Child, Preschool | 9 | 2021 | 36283 | 0.16 | Why? |
| Infant | 10 | 2021 | 30274 | 0.16 | Why? |
| Hyaluronic Acid | 1 | 2018 | 168 | 0.16 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.16 | Why? |
| Congenital Abnormalities | 1 | 2018 | 170 | 0.16 | Why? |
| Toes | 1 | 2018 | 252 | 0.16 | Why? |
| Chronic Disease | 3 | 2021 | 5139 | 0.15 | Why? |
| Pharyngitis | 2 | 2018 | 687 | 0.15 | Why? |
| Tacrolimus | 1 | 2019 | 435 | 0.15 | Why? |
| Child Welfare | 1 | 2021 | 405 | 0.15 | Why? |
| Olfactory Bulb | 1 | 2018 | 333 | 0.15 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.14 | Why? |
| Cyclosporine | 1 | 2019 | 449 | 0.14 | Why? |
| Specimen Handling | 3 | 2021 | 6190 | 0.14 | Why? |
| Child Health Services | 1 | 2021 | 520 | 0.14 | Why? |
| DNA, Bacterial | 1 | 2018 | 835 | 0.14 | Why? |
| Macrolides | 1 | 2017 | 369 | 0.13 | Why? |
| Preventive Medicine | 1 | 2017 | 242 | 0.13 | Why? |
| Autistic Disorder | 1 | 2018 | 253 | 0.13 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.13 | Why? |
| Analgesics | 1 | 2017 | 451 | 0.13 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.12 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.11 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.11 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.10 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.10 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.10 | Why? |
| Sleep Apnea, Obstructive | 1 | 2017 | 668 | 0.10 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.09 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Chromosome Deletion | 2 | 2018 | 62 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.09 | Why? |
| Emergency Service, Hospital | 3 | 2021 | 14232 | 0.09 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.08 | Why? |
| Diagnostic Techniques, Otological | 1 | 2005 | 1 | 0.08 | Why? |
| Humans | 26 | 2021 | 930598 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
| Male | 11 | 2021 | 367725 | 0.07 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.06 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Facies | 1 | 2018 | 15 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Chromosomes, Human, Pair 16 | 1 | 2018 | 11 | 0.05 | Why? |
| E1A-Associated p300 Protein | 1 | 2018 | 8 | 0.05 | Why? |
| CREB-Binding Protein | 1 | 2018 | 12 | 0.05 | Why? |
| Genes, Recessive | 1 | 2018 | 35 | 0.05 | Why? |
| Chromosomes, Human, Pair 9 | 1 | 2018 | 196 | 0.05 | Why? |
| Codon, Nonsense | 1 | 2018 | 66 | 0.05 | Why? |
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 82 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Exons | 1 | 2018 | 158 | 0.04 | Why? |
| Neuropsychiatry | 1 | 2018 | 81 | 0.04 | Why? |
| Mucociliary Clearance | 1 | 2018 | 72 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.04 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
| Nontuberculous Mycobacteria | 1 | 2018 | 114 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Child, Hospitalized | 1 | 2020 | 556 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Head | 1 | 2018 | 206 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Neck | 1 | 2018 | 307 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.03 | Why? |
| Brain | 2 | 2018 | 5133 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Parents | 2 | 2020 | 2758 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Rhinitis | 1 | 2018 | 626 | 0.03 | Why? |
| Sinusitis | 1 | 2018 | 649 | 0.03 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.02 | Why? |
| Cities | 1 | 2021 | 4937 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.02 | Why? |
| Hearing Loss, Conductive | 1 | 2005 | 13 | 0.02 | Why? |
| Schools | 1 | 2021 | 4187 | 0.02 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.02 | Why? |
| Mass Screening | 1 | 2005 | 8005 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Disability Evaluation | 1 | 2005 | 671 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Caregivers | 1 | 2005 | 3112 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Marchisio's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_